Logo

LexaGene

In Brief This Week: OpGen, MDxHealth, Dante Genomics, More

New items for the week of Oct. 24, 2022.

LexaGene, US Army to Test Automated Pathogen Detection System for Biothreats

The RT-PCR system was developed for veterinary diagnostic and food safety applications but is being tested for human pathogens under the cooperative R&D agreement.

New Products Posted to GenomeWeb: SomaLogic, LGC SeraCare, LexaGene, More

LexaGene Reports $58K in Fiscal Q4 Revenues, Spurred by MiQLab Launch

The Beverly, Massachusetts-based firm noted that all revenue from its MiQLab was generated from US customers.

LexaGene, Ethos Discovery to Develop Veterinary Infectious Disease Panels

Ethos Discovery will offer consulting services for identifying relevant targets in each panel based on disease prevalence and alignment with LexaGene's MiQLab platform.

Breaking News
The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.